These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12643742)

  • 21. Interactions of hairpin oligo-2'-O-methylribonucleotides containing methylphosphonate linkages with HIV TAR RNA.
    Hamma T; Miller PS
    Antisense Nucleic Acid Drug Dev; 2003 Feb; 13(1):19-30. PubMed ID: 12691533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antisense inhibition of human telomerase by phosphorothioate oligonucleotide-peptide conjugates.
    Diala I; Murao S; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):679-80. PubMed ID: 18776562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stepwise synthesis of oligonucleotide-peptide conjugates containing guanidinium and lipophilic groups in their 3'-termini.
    Grijalvo S; Terrazas M; Aviñó A; Eritja R
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2144-7. PubMed ID: 20206515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of peptide-oligonucleotide conjugates with single and multiple peptides attached to 2'-aldehydes through thiazolidine, oxime, and hydrazine linkages.
    Zatsepin TS; Stetsenko DA; Arzumanov AA; Romanova EA; Gait MJ; Oretskaya TS
    Bioconjug Chem; 2002; 13(4):822-30. PubMed ID: 12121138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient conjugation and characterization of distamycin-based peptides with selected oligonucleotide stretches.
    Ghosh S; Defrancq E; Lhomme JH; Dumy P; Bhattacharya S
    Bioconjug Chem; 2004; 15(3):520-9. PubMed ID: 15149179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A concise method for the preparation of peptide and arginine-rich peptide-conjugated antisense oligonucleotide.
    Chen CP; Zhang LR; Peng YF; Wang XB; Wang SQ; Zhang LH
    Bioconjug Chem; 2003; 14(3):532-8. PubMed ID: 12757376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LNA derivatives of a kissing aptamer targeted to the trans-activating responsive RNA element of HIV-1.
    Lebars I; Richard T; Di Primo C; Toulmé JJ
    Blood Cells Mol Dis; 2007; 38(3):204-9. PubMed ID: 17300966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.
    Moulton HM; Nelson MH; Hatlevig SA; Reddy MT; Iversen PL
    Bioconjug Chem; 2004; 15(2):290-9. PubMed ID: 15025524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Native chemical ligation in the synthesis of internally modified oligonucleotide-peptide conjugates.
    Diezmann F; Eberhard H; Seitz O
    Biopolymers; 2010; 94(4):397-404. PubMed ID: 20593471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved synthesis of daunomycin conjugates with triplex-forming oligonucleotides. The polypurine tract of HIV-1 as a target.
    Capobianco ML; De Champdoré M; Arcamone F; Garbesi A; Guianvarc'h D; B Arimondo P
    Bioorg Med Chem; 2005 May; 13(9):3209-18. PubMed ID: 15809156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, and evaluation of mitomycin-tethered phosphorothioate oligodeoxynucleotides.
    Huh N; Rege AA; Yoo B; Kogan TP; Kohn H
    Bioconjug Chem; 1996; 7(6):659-69. PubMed ID: 8950485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of high quality phosphorothioate oligonucleotides as antisense drugs. Use of I-linker in the elimination of 3'-terminal phosphorothioate monoesters.
    Ravikumar VT; Kumar RK; Capaldi DC; Cole DL
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1421-5. PubMed ID: 14565433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hybridase cleavage of RNA. II. Automatic synthesis of mixed oligonucleotide probes].
    Romanova EA; Oretskaia TS; Sukhomlinov VV; Krynetskaia NF; Metelev VG; Shabarova ZA
    Bioorg Khim; 1990 Oct; 16(10):1348-54. PubMed ID: 2085326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Site-specific cleavage of RNA and DNA by complementary DNA--bleomycin A5 conjugates.
    Vorobjev PE; Smith JB; Pyshnaya IA; Levina AS; Zarytova VF; Wickstrom E
    Bioconjug Chem; 2003; 14(6):1307-13. PubMed ID: 14624648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double sugar and phosphate backbone-constrained nucleotides: synthesis, structure, stability, and their incorporation into oligodeoxynucleotides.
    Zhou C; Plashkevych O; Chattopadhyaya J
    J Org Chem; 2009 May; 74(9):3248-65. PubMed ID: 19348480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New strategy for the synthesis of 3',5'-bifunctionalized oligonucleotide conjugates through sequential formation of chemoselective oxime bonds.
    Edupuganti OP; Singh Y; Defrancq E; Dumy P
    Chemistry; 2004 Nov; 10(23):5988-95. PubMed ID: 15497169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression, purification and characterization of TAT-high mobility group box-1A peptide as a carrier of nucleic acids.
    Kim K; Han JS; Kim HA; Lee M
    Biotechnol Lett; 2008 Aug; 30(8):1331-7. PubMed ID: 18347754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antisense sequence-directed cross-linking of DNA oligonucleotides by mitomycin C.
    Maruenda H; Tomasz M
    Bioconjug Chem; 1996; 7(5):541-4. PubMed ID: 8889014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gel shift assay: demonstration of enhanced binding of oligo(delta)-L-ornithine-oligodeoxynucleotide conjugates to complementary DNA and RNA.
    Zhu T; Pooyan S; Wei Z; Leibowitz MJ; Stein S
    Antisense Nucleic Acid Drug Dev; 1996; 6(1):69-74. PubMed ID: 8783798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of oligonucleotide-peptide conjugates for biomedical and technological applications.
    Aviñó A; Grijalvo S; Pérez-Rentero S; Garibotti A; Terrazas M; Eritja R
    Methods Mol Biol; 2011; 751():223-38. PubMed ID: 21674334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.